View in EDS

Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.

Saved in:
Bibliographic Details
Title: Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.
Authors: La Cerda J; Urology San Antonio, San Antonio, TX, USA., Thorley J; Intermountain Healthcare, Murray, UT, USA., Sieber P; Urological Associates of Lancaster, Lancaster, PA, USA., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Flanders SC; Sumitomo Pharma America Inc., Cambridge, MA, USA., Gatoulis SC; Pfizer Inc., New York, NY, USA., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
Source: Future oncology (London, England) [Future Oncol] 2025 Jan; Vol. 21 (1), pp. 51-62. Date of Electronic Publication: 2024 Nov 06.
Publication Type: Patient Education Handout
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39503549
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22La+Cerda+J%22">La Cerda J</searchLink>; Urology San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Thorley+J%22">Thorley J</searchLink>; Intermountain Healthcare, Murray, UT, USA.<br /><searchLink fieldCode="AU" term="%22Sieber+P%22">Sieber P</searchLink>; Urological Associates of Lancaster, Lancaster, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cookson+MS%22">Cookson MS</searchLink>; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.<br /><searchLink fieldCode="AU" term="%22Flanders+SC%22">Flanders SC</searchLink>; Sumitomo Pharma America Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gatoulis+SC%22">Gatoulis SC</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Shore+ND%22">Shore ND</searchLink>; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2025 Jan; Vol. 21 (1), pp. 51-62. <i>Date of Electronic Publication: </i>2024 Nov 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Patient Education Handout
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39503549
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2024.2409543
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 51
    Titles:
      – TitleFull: Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: La Cerda J
      – PersonEntity:
          Name:
            NameFull: Thorley J
      – PersonEntity:
          Name:
            NameFull: Sieber P
      – PersonEntity:
          Name:
            NameFull: Cookson MS
      – PersonEntity:
          Name:
            NameFull: Flanders SC
      – PersonEntity:
          Name:
            NameFull: Gatoulis SC
      – PersonEntity:
          Name:
            NameFull: Shore ND
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1